A dominant-negative F-box deleted mutant of E3 ubiquitin ligase, β-TrCP1/FWD1, markedly reduces myeloma cell growth and survival in mice

Por Sharma, Ramaswamy, Williams, Paul J., Gupta, Anjana, McCluskey, Brandon, Bhaskaran, Shylesh, Muñoz, Steve, Oyajobi, Babatunde O.
Publicado no Oncotarget (2015)

Increasing Wnt signaling in the bone marrow microenvironment inhibits the development of myeloma bone disease and reduces tumor burden in bone in vivo

Por Edwards, Claire M., Edwards, James R., Lwin, Seint T., Esparza, Javier, Oyajobi, Babatunde O., McCluskey, Brandon, Munoz, Steven, Grubbs, Barry, Mundy, Gregory R.
Publicado em 2008

Transdermal Lovastatin Enhances Fracture Repair in Rats

Por Gutierrez, Gloria E, Edwards, James R, Garrett, Ian R, Nyman, Jeffry S, McCluskey, Brandon, Rossini, Gianni, Flores, Alda, Neidre, Daria B, Mundy, Gregory R
Publicado em 2008

CCR1 blockade reduces tumor burden and osteolysis in vivo in a mouse model of myeloma bone disease

Por Dairaghi, Daniel J., Oyajobi, Babatunde O., Gupta, Anjana, McCluskey, Brandon, Miao, Shichang, Powers, Jay P., Seitz, Lisa C., Wang, Yu, Zeng, Yibin, Zhang, Penglie, Schall, Thomas J., Jaen, Juan C.
Publicado em 2012

Therapeutic anti-tumor efficacy of anti-CD137 agonistic monoclonal antibody in mouse models of myeloma

Por Murillo, Oihana, Arina, Ainhoa, Hervas-Stubbs, Sandra, Gupta, Anjana, McCluskey, Brandon, Dubrot, Juan, Palazón, Asís, Azpilikueta, Arantza, Ochoa, Maria C., Alfaro, Carlos, Solano, Sarai, Pérez-Gracia, José L., Oyajobi, Babatunde O., Melero, Ignacio
Publicado em 2008